Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Metabolon, Inc.
Editas regains rights to ocular programs first partnered with Allergan in 2017. Newly public F-star will focus on bispecific antibodies for cancer, TriSalus acquires oncology candidate from Dynavax.
Research centers are collaborating on projects to find causes of disease; Ampligen, Rituxan and KPAX-002 are only drugs in clinical trials.
NuBiyota is setting up a local presence to tap into China’s growing commitment to developing new therapeutics based on the microbiome, an area the country is increasingly supporting through central initiatives as part of a national precision medicine program, and where new partnerships are emerging.
Another slow month for VC financing deals means total deal value for 2016 to date is now lagging behind that for the same period last year.
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
- Urine-based Testing
Drug Discovery Tools
- Drug Discovery Tools